Advised Covalon Technologies Ltd. on its acquisition of AquaGuard for USD $12.4 million. The acquisition combines Covalon’s rich technology portfolio with AquaGuard’s excellent products and specialized salesforce, who will provide selling capabilities for and access to, the United States healthcare market; the largest healthcare market in the world.

Covalon researches, develops and commercializes new healthcare technologies that help save lives around the world. AquaGuard is a medical technology business that specializes in infection protection products that protect surgical incisions, IV sites, catheters, PICC lines, and other dressings from water and other moisture while a patient showers.

Future opportunities for Covalon lie in additional medical device technology companies; providing bolt-on opportunities in the infection control and management, surgical, vascular access and wound care markets.

SEE DEAL BRIEF